STOCK TITAN

IDenta Corp Reports Second Quarter 2024 Results with Impressive Increase in Revenue and Profitability

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

IDenta Corp (OTCQB: IDTA), a leader in field detection and home diagnostic testing kits for narcotics, explosives, and forensic products, reported impressive Q2 2024 results. Despite global challenges, the company showed significant growth:

- Revenue increased to $360,988 from $188,494 in Q2 2023
- Gross profit rose to $258,326 from $124,934
- Operating profit improved to $72,558 from a loss of $76,350
- Net profit reached $79,901, compared to a loss of $76,334
- Cash and cash equivalents grew to $461,850 from $264,294

CEO Amichai Glattstein attributed the success to wise resource management, new customer acquisition, and expansion in existing markets. The company remains committed to creating a better future for the world through its innovative products in homeland security and consumer markets.

IDenta Corp (OTCQB: IDTA), leader nel settore della rilevazione e dei kit di test diagnostici domestici per narcotici, esplosivi e prodotti forensi, ha riportato risultati impressionanti per il secondo trimestre del 2024. Nonostante le sfide globali, l'azienda ha mostrato una crescita significativa:

- I ricavi sono aumentati a $360,988 rispetto ai $188,494 del Q2 2023
- Il profitto lordo è salito a $258,326 rispetto ai $124,934
- Il profitto operativo è migliorato a $72,558 rispetto a una perdita di $76,350
- Il profitto netto ha raggiunto i $79,901, rispetto a una perdita di $76,334
- Liquidità e equivalenti di liquidità sono cresciuti a $461,850 dai $264,294

Il CEO Amichai Glattstein ha attribuito il successo a una gestione oculata delle risorse, all'acquisizione di nuovi clienti e all'espansione nei mercati esistenti. L'azienda rimane impegnata a creare un futuro migliore per il mondo attraverso i suoi prodotti innovativi nel settore della sicurezza interna e nei mercati consumer.

IDenta Corp (OTCQB: IDTA), líder en detección de campo y kits de pruebas diagnósticas en el hogar para narcóticos, explosivos y productos forenses, reportó resultados impresionantes en el segundo trimestre de 2024. A pesar de los desafíos globales, la empresa mostró un crecimiento significativo:

- Los ingresos aumentaron a $360,988 desde $188,494 en el Q2 2023
- El beneficio bruto subió a $258,326 desde $124,934
- El beneficio operativo mejoró a $72,558 desde una pérdida de $76,350
- El beneficio neto alcanzó los $79,901, comparado con una pérdida de $76,334
- Efectivo y equivalentes de efectivo crecieron a $461,850 desde $264,294

El CEO Amichai Glattstein atribuyó el éxito a una gestión inteligente de los recursos, la adquisición de nuevos clientes y la expansión en los mercados existentes. La compañía sigue comprometida a crear un futuro mejor para el mundo a través de sus productos innovadores en seguridad nacional y mercados de consumo.

IDenta Corp (OTCQB: IDTA)는 마약, 폭발물 및 법의학 제품을 위한 현장 탐지 및 가정 진단 테스트 키트 분야의 선두주자이며, 2024년 2분기 인상적인 결과를 보고했습니다. 글로벌 도전에도 불구하고 회사는 상당한 성장을 보여주었습니다:

- 수익은 2023년 2분기의 $188,494에서 $360,988로 증가했습니다.
- 매출 총이익은 $124,934에서 $258,326으로 상승했습니다.
- 영업 이익은 $76,350의 손실에서 $72,558로 개선되었습니다.
- 순이익은 $76,334의 손실과 비교하여 $79,901에 도달했습니다.
- 현금 및 현금성 자산은 $264,294에서 $461,850으로 증가했습니다.

CEO 아미카이 글라트슈타인은 성공의 원인을 자원 관리의 효율성, 신규 고객 확보 및 기존 시장의 확장으로 분석했습니다. 회사는 국내 안전 및 소비자 시장에서 혁신적인 제품을 통해 더 나은 미래를 만드는 데 전념하고 있습니다.

IDenta Corp (OTCQB: IDTA), leader dans la détection sur le terrain et les kits de tests diagnostiques pour les stupéfiants, les explosifs et les produits forensiques, a publié des résultats impressionnants pour le deuxième trimestre 2024. Malgré les défis mondiaux, l'entreprise a montré une croissance significative :

- Les revenus ont augmenté à 360,988 $ contre 188,494 $ au T2 2023
- Le bénéfice brut a augmenté à 258,326 $ contre 124,934 $
- Le bénéfice d'exploitation s'est amélioré à 72,558 $ contre une perte de 76,350 $
- Le bénéfice net a atteint 79,901 $, contre une perte de 76,334 $
- La trésorerie et équivalents de trésorerie ont crû à 461,850 $ contre 264,294 $

Le PDG Amichai Glattstein a attribué ce succès à une gestion prudente des ressources, à l'acquisition de nouveaux clients et à l'expansion sur les marchés existants. L'entreprise reste engagée à créer un avenir meilleur pour le monde grâce à ses produits innovants dans le domaine de la sécurité intérieure et des marchés de consommation.

IDenta Corp (OTCQB: IDTA), ein führendes Unternehmen im Bereich der Feldüberwachung und Heimdiagnosetests für Betäubungsmittel, Sprengstoffe und forensische Produkte, hat impressive Ergebnisse für das zweite Quartal 2024 berichtet. Trotz globaler Herausforderungen zeigte das Unternehmen signifikantes Wachstum:

- Der Umsatz stieg auf $360,988 von $188,494 im Q2 2023
- Der Bruttogewinn erhöhte sich auf $258,326 von $124,934
- Der Betriebsgewinn verbesserte sich auf $72,558 von einem Verlust von $76,350
- Der Nettogewinn erreichte $79,901, verglichen mit einem Verlust von $76,334
- Liquide Mittel wuchsen auf $461,850 von $264,294

CEO Amichai Glattstein führte den Erfolg auf eine kluge Ressourcennutzung, die Gewinnung neuer Kunden und die Expansion in bestehenden Märkten zurück. Das Unternehmen bleibt verpflichtet, eine bessere Zukunft für die Welt durch innovative Produkte im Bereich der Heimatschutz- und Verbrauchermärkte zu schaffen.

Positive
  • Revenue increased by 91.5% year-over-year to $360,988 in Q2 2024
  • Gross profit more than doubled to $258,326 in Q2 2024
  • Operating profit improved from a loss of $76,350 to a profit of $72,558
  • Net profit turned positive at $79,901 compared to a loss in Q2 2023
  • Cash and cash equivalents grew by 74.7% to $461,850
Negative
  • None.

HOLLYWOOD, Fla., Aug. 15, 2024 /PRNewswire/ -- IDenta Corp. (OTCQB: IDTA) is a worldwide leader in the development of Field Detection and Home Diagnostic Testing Kits for Narcotics, Explosives and Unique Forensic Products in Homeland Security and Consumer Markets. Today IDenta Corp reported its 2024 second quarter financial statement and shows an increase in sales and net profit. 

Mr. Amichai Glattstein, Chief Executive Officer, commented: " Despite the challenging global times for many  companies, our company is showing impressive results for 2024. The company continues to manage its resources wisely, grow with new customers and expands operations in existing markets. Our goal was and will continue to be a better future for the world".

Highlights of the Second Quarter of 2024 compared to the Second Quarter of 2023:

  • Revenues for the second quarter of 2024 were $360,988 compared to revenues of $188,494 in the second quarter of 2023.  
  • Gross profit increased to $258,326 in the second quarter of 2024 compared to gross profit of $124,934 in the second quarter of 2023.
  • Operating profit is $72,558 in the second quarter of 2024 compared to ($76,350) in the second quarter of 2023.  
  • Net profit for the second quarter of 2024 was $79,901 compared to net profit of ($76,334) in the second quarter of 2023.  
  • Cash and cash equivalents increased to $461,850 for the second quarter of 2024 compared to $264,294 for the second quarter of 2023.

About IDenta Corp.

IDenta Corp. is a global leader in the development and supply of Field Detection and Home Diagnostics Testing Kits for Drugs & Explosives and Unique Forensic Products in the Homeland Security and Consumer Markets. IDenta develops, manufactures and distributes revolutionary products for both the professional Law and Retail markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.

Safe Harbor Statement 

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Company Contact Information:
Public Relations
Tel: (240) 545-6646
E: pr@identa-corp.com

Cision View original content:https://www.prnewswire.com/news-releases/identa-corp-reports-second-quarter-2024-results-with-impressive-increase-in-revenue-and-profitability-302223613.html

SOURCE IDenta Corp.

FAQ

What was IDenta Corp's (IDTA) revenue in Q2 2024?

IDenta Corp (IDTA) reported revenue of $360,988 in Q2 2024, a significant increase from $188,494 in Q2 2023.

How much profit did IDenta Corp (IDTA) make in Q2 2024?

IDenta Corp (IDTA) reported a net profit of $79,901 in Q2 2024, compared to a net loss of $76,334 in Q2 2023.

What was IDenta Corp's (IDTA) cash position at the end of Q2 2024?

IDenta Corp (IDTA) reported cash and cash equivalents of $461,850 at the end of Q2 2024, up from $264,294 in Q2 2023.

How did IDenta Corp's (IDTA) gross profit change in Q2 2024?

IDenta Corp's (IDTA) gross profit increased to $258,326 in Q2 2024, up from $124,934 in Q2 2023.

IDENTA CORP

OTC:IDTA

IDTA Rankings

IDTA Latest News

IDTA Stock Data

2.27M
4.05M
Diagnostics & Research
Healthcare
Link
United States of America
Jerusalem